Alnylam Pharmaceuticals, Inc.ALNYNASDAQ
Loading
ROE: Strong ReturnsExpanding
Percentile Rank86
3Y CAGR-61.8%
Year-over-Year Change
Return on equity
3Y CAGR
-61.8%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 39.76% | +109.6% |
| 2024 | -414.62% | -307.8% |
| 2023 | 199.53% | -72.1% |
| 2022 | 714.91% | +593.1% |
| 2021 | -144.99% | -71.7% |
| 2020 | -84.46% | -37.1% |
| 2019 | -61.59% | -5.3% |
| 2018 | -58.49% | -110.5% |
| 2017 | -27.79% | +37.6% |
| 2016 | -44.57% | - |